The Liquid Biopsy and Tumor Progression in Breast Cancer
1 – 10 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
Gunnarsdottir, Frida Björk LU ; Bendahl, Pär Ola LU ; Johansson, Alexandra ; Benfeitas, Rui ; Rydén, Lisa LU
; Bergenfelz, Caroline
LU
and Larsson, Anna Maria
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
Gulis, K. LU
; Ellbrant, J.
LU
; Svensjö, T.
LU
; Skarping, I.
LU
; Vallon-Christersson, J.
LU
; Loman, N.
LU
; Bendahl, P. O.
LU
and Rydén, L.
LU
(2023)
In European Journal of Surgical Oncology
- Contribution to journal › Article
-
Mark
Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
Bengtsson, Ylva LU
; Demircan, Kamil
; Vallon-Christersson, Johan
LU
; Malmberg, Martin
; Saal, Lao
LU
; Ryden, Lisa
LU
; Borg, Åke
LU
; Schomburg, Lutz
; Sandsveden, Malte
LU
and Manjer, Jonas
LU
(2023)
In Redox Biology
63.
- Contribution to journal › Article
-
Mark
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
Egelberg, Moa LU
; De Marchi, Tommaso
LU
; Pekar, Gyula
LU
; Tran, Lena
LU
; Bendahl, Pär Ola
LU
; Tullberg, Axel Stenmark
; Holmberg, Erik
; Karlsson, Per
; Farnebo, Marianne
and Killander, Fredrika
LU
, et al.
(2023)
In Molecular Oncology
- Contribution to journal › Article
-
Mark
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI) : a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
Lång, Kristina LU ; Josefsson, Viktoria LU ; Larsson, Anna-Maria LU ; Larsson, Stefan LU ; Högberg, Charlotte LU
; Sartor, Hanna
LU
; Hofvind, Solveig
; Andersson, Ingvar
LU
and Rosso, Aldana
LU
(2023)
In The Lancet. Oncology
24(8).
p.936-944
- Contribution to journal › Article
-
Mark
The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
Dihge, Looket LU ; Bendahl, Pär Ola LU ; Skarping, Ida LU
; Hjärtström, Malin
LU
; Ohlsson, Mattias
LU
and Rydén, Lisa
LU
(2023)
In Frontiers in Oncology
13.
- Contribution to journal › Article
-
Mark
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer : A Swedish retrospective cohort study
Thurell, Jacob ; Manouchehri, Narges ; Fredriksson, Irma ; Wilking, Ulla ; Bergh, Jonas ; Ryden, Lisa LU
; Koppert, Linetta B.
; Karsten, Maria M.
; Kiani, Narsis A.
and Hedayati, Elham
(2023)
In Breast
70.
p.18-24
- Contribution to journal › Article
-
Mark
Breast Cancer Diagnosis Using Extended-Wavelength–Diffuse Reflectance Spectroscopy (EW-DRS) : Proof of Concept in Ex Vivo Breast Specimens Using Machine Learning
Chaudhry, Nadia LU ; Albinsson, John LU ; Cinthio, Magnus LU ; Kröll, Stefan LU ; Malmsjö, Malin LU ; Rydén, Lisa LU
; Sheikh, Rafi
LU
; Reistad, Nina
LU
and Zackrisson, Sophia
LU
(2023)
In Diagnostics
13(19).
p.1-12
- Contribution to journal › Article
-
Mark
Investigating the prognostic value of mammographic breast density and mammographic tumor appearance in women with invasive breast cancer : The Malmö Diet and cancer study
Sturesdotter, Li LU
; Larsson, Anna Maria
LU
; Zackrisson, Sophia
LU
and Sartor, Hanna
LU
(2023)
In Breast
70.
p.8-17
- Contribution to journal › Article
-
Mark
Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer : A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin
- Contribution to journal › Article